For example, ENO2 was involved in the oncogenic process of BRAF V600E colorectal cancer by regulating the MAPK/ERK signaling pathway and may be a novel therapeutic target for BRAF V600E mutant colorectal cancer [28]. Here, BRAF is linked to colorectal cancer.